Anuh Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Anuh Pharma Ltd. on BSE

Load latest

Anuh Pharma Ltd.

04 Jan 2025

171.55

-1.24%

Company Update

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Intimation of Change in Rating Outlook by ICRA Credit Rating Limited under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Anuh Pharma Ltd.

28 Dec 2024

171.55

-1.24%

Company Update

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication for transfer of equity shares of the Company for which Dividend has not been claimed by shareholders for seven consecutive years or more to Investor Education and Protection Fund (IEPF), published in Financial Express (English) and Mumbai Lakshadeep (Marathi).

pdf

Anuh Pharma Ltd.

26 Dec 2024

171.55

-1.24%

SAST

ANUH PHARMA LTD. - 506260 - Closure of Trading Window

BSE India

Intimation regarding the Closure of Trading Window for dealing in securities of the Company shall remain closed from Wednesday, 01st January, 2025 till the expiry of 48 hours after the declaration of Unaudited Financial Results for the Quarter ended 31st December, 2024.

pdf

Anuh Pharma Ltd.

18 Dec 2024

171.55

-1.24%

Company Update

ANUH PHARMA LTD. - 506260 - Announcement Under Regulation 30 (LODR) - Listing And Trading Approval …

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we, Anuh Pharma Limited, are pleased to submit that the Company has received listing and trading approval from NSE for listing of the equity shares of the Company vide letter dated 18th December, 2024. Hence, w.e.f. 20th December, 2024 the Company will also be listed on the National Stock Exchange of India Limited.

pdf

Anuh Pharma Ltd.

02 Dec 2024

171.55

-1.24%

Company Update

ANUH PHARMA LTD. - 506260 - Announcement Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

As per attached Representation for Withdrawal of fines and penal action initiated by your good office, we request you to kindly take note that we are in compliance with the Regulation 18(1) of SEBI (LODR), 2015.

pdf

Anuh Pharma Ltd.

29 Nov 2024

171.55

-1.24%

Investor Presentation

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for Q2 FY2024-25

pdf

Anuh Pharma Ltd.

26 Nov 2024

171.55

-1.24%

Company Update

ANUH PHARMA LTD. - 506260 - Disclosure Pursuant To Regulation 30 Of The Securities And Exchange …

BSE India

Pursuant to our letter dated 31st May, 2024, informing that Anuh Pharma Limited had signed a definitive agreement to subscribe for the equity share capital in Huoban Energy 5 Private Limited. It is hereby informed that the Company has completed its subscription in equity share capital of Huoban Energy 5 Private Limited on 26th November, 2024.

pdf

Anuh Pharma Ltd.

15 Nov 2024

171.55

-1.24%

Company Update

ANUH PHARMA LTD. - 506260 - Announcement Under Regulation 30 (LODR) - Inaugration Of Plant 3 …

BSE India

This is to inform that the Company has inaugrated its new Plant API-3 at E-17/3, E-17/4 & E-18, M.I.D.C., Tarapur, Biosar, Dist Palghar - 401506, India on 15th November, 2024.

pdf

Anuh Pharma Ltd.

15 Nov 2024

171.55

-1.24%

Company Update

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

In furtherance to our Disclosure under Regulation 30 for Newspaper publication for Unaudited Financial Results for the Quarter and half year ended 30th September, 2024 being published on 09th November, 2024, please find enclosed herewith the newspaper cutting of the corrigendum published in Mumbai Lakshdeep (Marathi Language) on 15th November, 2024

pdf

Anuh Pharma Ltd.

14 Nov 2024

171.55

-1.24%

Company Update

ANUH PHARMA LTD. - 506260 - Non-Applicability Of Statement For Deviation(S) Or Variation(S) Under Regulation 32 …

BSE India

Non-Applicability of Statement for Deviation(s) or Variation(s) under Regulation 32 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Is Anuh Pharma Ltd. worth buying?

225 Votes:

Buy 72.89%

Sell 10.67%

Hold 16.44%